StockWatch
·

SREE RAYALASEEMA HI-STRENGTH HYPO LTD. Q2 FY27 Results

SRHHYPOLTDQ2 FY27 Results
Filing
Result:Good· Market: Up#Broad based#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue246.4116.8%35.1%
Total Income256.5916.2%35.4%
Expenditure213.5416.4%35.4%
PBT44.1530.2%38.7%
Net Profit32.7032.2%40.4%
OPM14.74%2.25pp0.04pp
NPM12.74%1.54pp0.45pp
EPS19.1831.9%41.3%
View full financials

Chemicals sector lens on adjusted PAT/revenue growth: adjusted PAT +~36% and revenue +35% on volume-led growth is well above-average, but core operating margin was flat-to-down YoY (~14.3% vs 14.8%) with the margin optics propped up by other income, capping it below very_good.

Q2 FY-2027 RESULTS · SRHHYPOLTD

Sree Rayalaseema Hypo Q2FY27: consolidated PAT +40% YoY, revenue +35%, margins expand

PAT +40.39% YoY · revenue +35.11% · margins expanding

14 Nov 2026 · 3 min read
Revenue

₹246.41 Cr

+35.11% YoY

PAT (consolidated)

₹32.7 Cr

+40.39% YoY

Net margin

12.74%

+0.5pp YoY

EPS

₹19.18

Consolidated PAT for the quarter ended September 30, 2026 rose 40% YoY to ₹32.70 Cr (owners' share ₹32.92 Cr) on revenue from operations of ₹246.41 Cr, up 35% YoY and 17% QoQ. The quarter carries a small ₹1.11 Cr exceptional gain booked on gold futures, versus nil in the year-ago quarter; stripping it out, adjusted YoY PAT growth works out to roughly 36% (adjusted PAT ≈ ₹31.6 Cr) against the 40% reported, so the underlying print is only modestly softer than the headline. Standalone PAT of ₹33.13 Cr sits within 2% of the consolidated number, so the choice of basis doesn't change the read.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹246.41 Cr+16.8%+35.1%
Expenses₹213.54 Cr+16.4%+35.4%
PAT₹32.7 Cr+32.21%+40.39%
Net margin12.74%+1.5pp+0.5pp
EPS₹19.18+31.9%+41.3%

Net profit margin expanded to 12.74% from 12.29% a year ago and 11.20% last quarter, but the improvement leans more on a 43% YoY jump in other income (₹10.17 Cr vs ₹7.10 Cr) and a lower effective tax rate (25.9% vs 26.8% YoY) than on core operations: the operating margin (profit before exceptional items/tax, adjusted for other income, finance cost and depreciation, as a % of revenue from operations) was roughly flat-to-down YoY at ~14.3% against 14.8% in Q2 FY26, even as it ticked up slightly from ~14.2% in Q1 FY27. Cost of materials consumed, the largest expense line, rose broadly in step with revenue (₹133.20 Cr vs ₹89.95 Cr YoY), consistent with volume-led rather than margin-led topline growth.

₹
448.05497.78547.5597.22646.9551708-1109-0209-2510-2111-1211-13
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹517, down 6% over the past month of trading.

₹ Cr
09.2318.4627.722Q4 FY25rev ₹160 Cr22.41Q1 FY26rev ₹180 Cr23.29Q2 FY26rev ₹182 Cr23.75Q3 FY26rev ₹141 Cr20.06Q4 FY26rev ₹163 Cr24.73Q1 FY27rev ₹211 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.

There is no published analyst coverage or consensus estimate for this stock this quarter, so vsStreet is unknown rather than a miss; management has also issued no formal guidance on record to grade the print against, and no press release or commentary accompanied the regulatory filing beyond the standard board-outcome letter. The quarter's other corporate developments — the trading-window closure ahead of results, the special window for physical share transfers, and K Phaneendra Rao's induction as an independent director following another director's completed tenure — are governance and administrative matters that don't bear on the chemicals/wind-power operating numbers reported here.

  • W1

    Whether other income (₹10.17 Cr this quarter, +43% YoY) normalizes next quarter — it's the main driver of the NPM gain over the flatter OPM.

  • W2

    Core operating margin trajectory — OPM was flat-to-down YoY (~14.3% vs 14.8%); watch if cost of materials (₹133.2 Cr, up with revenue) keeps pace with or outpaces sales next quarter.

  • W3

    H1 FY27 PAT already at ~64% of FY26's full year (₹90.15 Cr) — whether H2 sustains this run-rate to beat the full-year FY26 PAT.

Informational and educational content only. Not investment advice.